The DCNN works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development.
|Andrew West, PhD
Director, Duke Center for Neurodegeneration and Neurotherapeutics
Professor of Pharmacology and Cancer Biology
Read Dr. West’s “Profiles in Brain Sciences” interview here.